Evidence map›Paper›PMID 31177363›Full record

ReviewCurrent HIV/AIDS reports2019

Implementation Strategies to Increase PrEP Uptake in the South.

Patrick S Sullivan, Leandro Mena, Latesha Elopre, Aaron J Siegler

Registry-linked trialAbstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06141408 (A Community-based Intervention to Increase PrEP Initiation in Prince George's County, Maryland), which is not on this map. Cited by 157 papers.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06141408 narecruitingnot on this mapstarted 2022, after this paper: background citation

A Community-based Intervention to Increase PrEP Initiation in Prince George's County, Maryland: Reducing HIV Stigma and Increasing Social Support

TypeinterventionalSponsorGeorge Mason UniversityRan2022 to 2026Enrolled120ConditionsHiv, Mental Health Issue, Support, FamilyArmsMPowerment PrEP Promotion Intervention
3 · Its place in the literature

Who cites it

157 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patrick S SullivanRollins School of Public Health, Department of Epidemiology, Emory University, 1518 Clifton Road NE, Room 464, Atlanta, GA, 30322, USA. pssulli@emory.edu.
Leandro MenaJohn D. Bower School of Population Health, Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS, USA.
Latesha ElopreSchool of Medicine, University of Alabama, Birmingham, AL, USA.
Aaron J SieglerRollins School of Public Health, Department of Behavioral Sciences and Health Education, Emory University, Atlanta, GA, USA.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuumU19HD089881 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HIGHTOW-WEIDMAN, LISA B, SULLIVAN, PATRICK SEAN · 2016 to 2022
$35.8M
Making it last: A randomized, controlled trial of a home care system to promote persistence in PrEP careR01MH114692 · NIMH · EMORY UNIVERSITY · PI MAYER, KENNETH H, SIEGLER, AARON JULIUS · 2017 to 2021
$5.8M
Theoretically Based Mobile App to Increase PrEP Uptake Among MSMR01DA045612 · NIDA · EMORY UNIVERSITY · PI SULLIVAN, PATRICK SEAN · 2017 to 2021
$5.2M
Understanding substance use and incident HIV/STI among young black MSMR01DA038196 · NIDA · EMORY UNIVERSITY · PI ROSENBERG, ELI SAMUEL, SULLIVAN, PATRICK SEAN · 2014 to 2018
$3.2M
National Health Literacy Mapping to Inform Healthcare PolicyR01AG046267 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BAILEY, STACY C, FANG, GANG · 2014 to 2017
$1.6M
NIAID NIH HHS P30 AI050409NIA NIH HHS R01 AG046267NICHD NIH HHS U19 HD089881NIDA NIH HHS R01 DA038196NIDA NIH HHS R01 DA045612NIMH NIH HHS R01 MH114692
6 · The paper itself

Abstract

purpose of reviewSeven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South. RECENT

findingsPublished literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act-compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications. Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.

Indexed as

Anti-HIV AgentsEmtricitabineEpidemicsHIV InfectionsHomosexuality, MaleHumansMaleMass ScreeningMedication AdherencePatient Protection and Affordable Care ActPre-Exposure ProphylaxisSafe SexSexual and Gender MinoritiesSocial StigmaTelemedicineTenofovirAnti-HIV AgentsEmtricitabineTenofovirHIV preventionMultisectoral responsesPre-exposure prophylaxis (PrEP)

Identifiers

PMID31177363
PMCPMC7117066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.